# US 2013/0295186 A1 · Method for coating particles with calcium phosphate and particles, microparticles and nanoparticles formed thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0295186 A1
- Document ID: US20130295186A1
- Status: Published application
- Kind: A1
- Application number: 13/885,931
- Filed: 2011-11-24
- Published: 2013-11-07
- Earliest claimed: 2010-11-24
- Inventors: Say Chye Joachim Loo; Kelsen Bastari; Subramaniam Venkatraman
- Web page: https://patentgrep.com/patent/US20130295186A1

## CPC

- A61K 47/02: Inorganic compounds
- A61K 9/501: {Inorganic compounds}
- A61K 9/5026: {obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates}
- A61K 9/5115: {Inorganic compounds}
- A61K 9/5138: {obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates}
- A61L 27/18: obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
- A61L 27/32: Phosphorus-containing materials, e.g. apatite
- C08J 3/128: {Polymer particles coated by inorganic and non-macromolecular organic compounds}
- A61L 2430/02: for reconstruction of bones; weight-bearing implants
- C08J 2300/16: Biodegradable polymers
- C08J 2367/04: Polyesters derived from hydroxy carboxylic acids, e.g. lactones (C08J2367/06 takes precedence)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- C08J: WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H (working, e.g. shaping, of plastics B29)

## Abstract

The present invention relates to a method for coating particles with calcium phosphate (CaP), wherein the particles are negatively charged. The method includes contacting the particles with a first solution containing calcium ions, removing the first solution to obtain a precipitate, and contacting the precipitate with a second solution containing phosphate ions to obtain CaP-coated particles.

## Claims

### Claim 1

A method for coating particles with calcium phosphate (CaP), wherein the particles are negatively charged, the method comprising:
contacting the particles with a first solution containing calcium ions;
removing the first solution to obtain a precipitate; and
contacting the precipitate with a second solution containing phosphate ions to obtain CaP-coated particles.

### Claim 2 (depends on 1)

The method of claim 1, wherein the negatively charged particles comprise a polymer or polymer mixture.

### Claim 3 (depends on 2)

The method of claim 2, wherein the polymer is selected from the group consisting of poly(lactic-co-glycolic acid) (PLGA), poly(lactic acid) (PLA), poly(ethyleneglycol) (PEG), poly(L-lactic) (PLLA), polycaprolactone (PCL), and mixtures thereof

### Claim 4 (depends on 2, 3)

The method of claim 2 or 3, wherein the negatively charged particles comprise a negatively charged compound.

### Claim 5 (depends on 4)

The method of claim 4, wherein the negatively charged compound is a surfactant.

### Claim 6 (depends on 5)

The method of claim 5, wherein the surfactant is selected from the group consisting of sodium dodecyl sulfate (SDS) and poly(ethylene-alt-maleic anhydride) (PEMA), and poly(vinyl alcohol) (PVA).

### Claim 7

The method of any one of the preceding claims, wherein the particles are produced by the emulsion solvent evaporation method comprising dissolving the particle material and a suitable solvent, adding the solution to an aqueous solution containing a negatively charged surfactant to form an emulsion, adding the emulsion to an aqueous solution containing a negatively charged surfactant and evaporating the solvent; and collecting the negatively charged particles from the aqueous solution.

### Claim 8

The method of any one of the preceding claims, wherein the first solution is selected from the group consisting of calcium nitrate tetrahydrate solution and calcium chloride.

### Claim 9

The method of any one of the preceding claims, wherein the second solution is selected from the group consisting of ammonium dihydrogenphosphate solution, disodium hydrogen phosphate, dipotassium hydrogen phosphate, and orthophosphoric acid.

### Claim 10

The method of any one of the preceding claims, further comprising adding a base to the first solution and/or second solution to maintain the pH in the range of about 10 to 12.

### Claim 11

The method of any one of the preceding claims, wherein contacting the particles with the first solution comprises adding the particles to the first solution and stirring the solution for between about 5 minutes and about 5 hours.

### Claim 12

The method of any one of the preceding claims, wherein contacting the particles with the second solution comprises adding the precipitate to the second solution and stirring the solution for between about 2 minutes and 3 days.

### Claim 13

The method of any one of the preceding claims, wherein the ratio of concentration of the first solution to the concentration of the second solution is in the range of about 5:1 to about 1:1.

### Claim 14

The method of any one of the preceding claims, wherein the particles comprise particles formed of a surface-modified structure with the use of surfactants.

### Claim 15

The method of any one of the preceding claims, wherein the particles comprise particles comprising a pharmaceutically active compound.

### Claim 16 (depends on 15)

The method of claim 15, wherein the pharmaceutically active compound is encapsulated within the polymer.

### Claim 17

The method of any one of the preceding claims, further comprising separating the CaP-coated particles from the second solution.

### Claim 18 (depends on 17)

The method of claim 17, wherein the separation is achieved by centrifuging the mixture to obtain the CaP-coated particles.

### Claim 19 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18)

A particle coated with calcium phosphate (CaP), wherein the particle is obtained by a method of any one of claims 1-18.

### Claim 20

A microparticle comprising a negatively charged particle coated with calcium phosphate (CaP), wherein calcium ions of the CaP are absorbed onto the surface of the negatively charged particle, and wherein the microparticle has a diameter of about 50 to 200 μm.

### Claim 21 (depends on 20)

The microparticle of claim 20, wherein the diameter is about 1 to 20 μm.

### Claim 22

A nanoparticle comprising a negatively charged particle coated with calcium phosphate (CaP), wherein calcium ions of the CaP are absorbed onto the surface of the negatively charged particle, and wherein the nanoparticle has a diameter of about 50 to 500 nm.

### Claim 23 (depends on 19, 20, 22)

Use of the particle of claim 19, microparticle of claim 20, or nanoparticle of claim 22 for drug delivery.

### Claim 24 (depends on 23)

The use of claim 23 for drug delivery to an osseous structure.
